Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation
Open Access
- 7 December 2021
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 148 (11) , 3015-3028
Abstract
Purpose: In Germany, almost every other colorectal cancer (CRC) patient undergoes inpatient cancer rehabilitation (ICR), but research on long-term outcomes is sparse. We aimed to assess health-related quality of life (HRQOL), distress, and posttraumatic growth among former rehabilitants and non-rehabilitants as well as respective differences and to estimate disease-related quality of life deficits in both groups. Methods: HRQOL (EORTC-QLQ-C30/CR29), distress (QSC-R10), and posttraumatic growth (PTGI) were assessed according to past ICR in patients 5-year post-CRC-diagnosis in the German DACHS study. Least square mean differences in HRQOL scores and elevated distress levels (QSC-R10 > 14 points) by ICR were estimated by confounder-adjusted linear and logistic regression, respectively. Differences in PTGI scales were tested for statistical significance. EORTC-QLQ-C30 reference scores from population controls were accessed from the LinDE study to estimate disease-related deficits in both treatment groups. Results: 49% of the included 1906 CRC survivors had undergone ICR. Rehabilitants reported lower HRQOL scores than non-rehabilitants in several dimensions of the EORTC-QLQ-C30/CR29. Differences were pronounced among younger survivors (< 70 years). In younger survivors, past ICR also predicted elevated distress. However, rehabilitants showed higher posttraumatic growth. When compared to 934 population controls, non-rehabilitants and older rehabilitants reported HRQOL scores (EORTC-QLQ-C30) similar to controls except higher levels of bowel dysfunctions, whereas younger rehabilitants experienced deficits regarding most scales (13/15). Conclusion: Our findings suggest a high disease burden 5 years after diagnosis in particular among younger CRC survivors who had undergone ICR. Observed HRQOL deficits are possibly linked to the initial indication for ICR and rehabilitants may benefit from effective follow-up concepts after ICR.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01GL1712)
- Deutsches Krebsforschungszentrum (DKFZ)
This publication has 45 references indexed in Scilit:
- Normative Data of the EORTC QLQ-C30 For the German Population: A Population-Based SurveyPLOS ONE, 2013
- Health-Related Quality of Life Among Long-Term Survivors of Colorectal Cancer: A Population-Based StudyThe Oncologist, 2011
- Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of lifeBritish Journal of Cancer, 2011
- Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancerEuropean Journal of Cancer, 2009
- Posttraumatic growth and PTSD symptomatology among colorectal cancer survivors: a 3‐month longitudinal examination of cognitive processingPsycho-Oncology, 2008
- Short-term moderate exercise programs reduce oxidative DNA damage as determined by high-performance liquid chromatography-electrospray ionization-mass spectrometry in patients with colorectal carcinoma following primary treatmentScandinavian Journal of Gastroenterology, 2008
- Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaireEuropean Journal of Cancer, 2007
- Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatmentCancer Detection Prevention, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987